Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: A systematic review

Addiction

Volumn 109, Issue 4, 2014, Pages 547-557

  Bagot, Kara Simone ^a   Kaminer, Yifrah ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Abuse; Cognitive; Enhancement; Healthy; Misuse; Neurocognitive; Non ADHD; Stimulants; Youth.

Indexed keywords

AMPHETAMINE; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; MODAFINIL; NOOTROPIC AGENT;

ADOLESCENT; ADULT; ATTENTION; COGNITION; DRUG EFFECTS; HUMAN; PROBLEM SOLVING; RECALL; YOUNG ADULT;

ADOLESCENT; ADULT; AMPHETAMINE; ATTENTION; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; HUMANS; MENTAL RECALL; METHYLPHENIDATE; NOOTROPIC AGENTS; PROBLEM SOLVING; YOUNG ADULT;

EID: 84896716363     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12460     Document Type: Review

References (46)

1. Johnston L. D., O'Malley P. M., Bachman J. G., Schulenberg J. E. Monitoring the Future national results on adolescent drug use: overview of key findings, 2011. Ann Arbor, MI: The University of Michigan, Institute for Social Research; 2012.
2. National Institute on Drug Abuse (NIDA). Topics in Brief: Prescription Drug Abuse. Bethesda, MD: NIDA; 2011.
3. Substance Abuse and Mental Health Services (SAMHSA). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: SAMHSA; 2011.
4. Swanson J. M., Volkow N. D. Increasing use of stimulants warns of potential abuse. Nature 2008; 453: 586.
5. Kaminer Y., Winters K. C. Clinical Manual of Adolescent Substance Abuse Treatment. Arlington, VA: American Psychiatric Publishing; 2010.
6. Swanson J. M., Wigal T. L., Volkow N. D. Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah (2011). Psychol Bull 2011; 137: 742-748.
7. Schwarz A. Risky rise of the good-grade pill. New York Times, 10 June 2012. Available at: http://www.nytimes.com/2012/06/10/education/seeking-academic-edge-teenagers-abuse-stimulants.html?pagewanted=all (accessed 16 January 2014) (Archived at http://www.webcitation.org/6Mg2VI375 on 16 January 2014).
8. Schwarz A. Drowned in a stream of prescriptions. New York Times, 3 February 2013. Available at: http://www.nytimes.com/2013/02/03/us/concerns-about-adhd-practices-and-amphetamine-addiction.html (accessed 16 January 2014) (Archived at http://www.webcitation.org/6Mg2lKXDA on 16 January 2014).
9. Schwarz A. Attention disorder or not, pills to help in school. New York Times, 9 October 2012. Available at: http://www.nytimes.com/2012/10/09/health/attention-disorder-or-not-children-prescribed-pills-to-help-in-school.html?pagewanted=all (accessed 16 January 2014) (Archived at http://www.webcitation.org/6Mg2sfdv4 on 16 January 2014).
10. Kroutil L. A., Van Brunt D. L., Herman-Stahl M. A., Heller D. C., Bray R. M., Penne M. A. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 2006; 84: 135-143.
11. Wilens T. E., Adler L. A., Adams J., Sgambati S., Rotrosen J., Sawtelle R. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008; 47: 21-31.
12. Bostrom N., Sandberg A. Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics 2009; 15: 311-341.
13. Heinz A., Kipke R., Heimann H., Wiesing U. Cognitive neuroenhancement: false assumptions in the ethical debate. J Med Ethics 2012; 38: 372-375.
14. Teter C. J., McCabe S. E., LaGrange K., Cranford J. A., Boyd C. J. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006; 26: 1501-1510.
15. Teter C. J., McCabe S. E., Cranford J. A., Boyd C. J., Guthrie S. K. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health 2005; 53: 253-262.
16. Stewart-Williams S., Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 2004; 130: 324-340.
17. Mitchell S. H., Laurent C. L., de Wit H. Interaction of expectancy and the pharmacological effects of d-amphetamine: subjective effects and self-administration. Psychopharmacology (Berl) 1996; 125: 371-378.
18. Volkow N. D., Swanson J. M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003; 160: 1909-1918.
19. Looby A., Earleywine M. Expectation to receive methylphenidate enhances subjective arousal but not cognitive performance. Exp Clin Psychopharmacol 2011; 19: 433-444.
20. Koelega H. S. Stimulant drugs and vigilance performance: a review. Psychopharmacology (Berl) 1993; 111: 1-16.
21. Advokat C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev 2010; 34: 1256-1266.
22. Greely H., Sahakian B., Harris J., Kessler R. C., Gazzaniga M., Campbell P. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008; 456: 702-705.
23. Thaler D. S. Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs. Harm Reduct J 2009; 6: 10.
24. Turner D. C., Robbins T. W., Clark L., Aron A. R., Dowson J., Sahakian B. J. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 2003; 165: 260-269.
25. Marchant N. L., Kamel F., Echlin K., Grice J., Lewis M., Rusted J. M. Modafinil improves rapid shifts of attention. Psychopharmacology (Berl) 2009; 202: 487-495.
26. Baranski J. V., Pigeau R. A. Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. J Sleep Res 1997; 6: 84-91.
27. Baranski J. V., Pigeau R., Dinich P., Jacobs I. Effects of modafinil on cognitive and meta-cognitive performance. Hum Psychopharmacol 2004; 19: 323-332.
28. Caldwell J. A. Jr, Caldwell J. L., Smythe N. K. III, Hall K. K. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl) 2000; 150: 272-282.
29. Killgore W. D., Kahn-Greene E. T., Grugle N. L., Killgore D. B., Balkin T. J. Sustaining executive functions during sleep deprivation: a comparison of caffeine, dextroamphetamine, and modafinil. Sleep 2009; 32: 205-216.
30. Elliott R., Sahakian B. J., Matthews K., Bannerjea A., Rimmer J., Robbins T. W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) 1997; 131: 196-206.
31. Aron A. R., Dowson J. H., Sahakian B. J., Robbins T. W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2003; 54: 1465-1468.
32. Naylor H., Halliday R., Callaway E. The effect of methylphenidate on information processing. Psychopharmacology (Berl) 1985; 86: 90-95.
33. Rogers R. D., Blackshaw A. J., Middleton H. C., Matthews K., Hawtin K., Crowley C. etal. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl) 1999; 146: 482-491.
34. Hester R., Nandam L. S., O'Connell R. G., Wagner J., Strudwick M., Nathan P. J. etal. Neurochemical enhancement of conscious error awareness. J Neurosci 2012; 32: 2619-2627.
35. Holroyd C. B., Coles M. G. The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol Rev 2002; 109: 679-709.
36. Linssen A. M., Vuurman E. F., Sambeth A., Riedel W. J. Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers. Psychopharmacology (Berl) 2012; 221: 611-619.
37. Rapoport J. L., Buchsbaum M. S., Zahn T. P., Weingartner H., Ludlow C., Mikkelsen E. J. Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 1978; 199: 560-563.
38. Rapoport J. L., Buchsbaum M. S., Weingartner H., Zahn T. P., Ludlow C., Mikkelsen E. J. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 1980; 37: 933-943.
39. Soetens E., Casaer S., D'Hooge R., Hueting J. E. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology (Berl) 1995; 119: 155-162.
40. Farah M. J., Haimm C., Sankoorikal G., Smith M. E., Chatterjee A. When we enhance cognition with dextroamphetamine, do we sacrifice creativity? A preliminary study. Psychopharmacology (Berl) 2009; 202: 541-547.
41. Ilieva I., Boland J., Farah M. J. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology 2013; 64: 496-505.
42. Mattay V. S., Goldberg T. E., Fera F., Hariri A. R., Tessitore A., Egan M. F. etal. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 2003; 100: 6186-6191.
43. Dyme I. Z., Sahakian B. J., Golinko B. E., Rabe E. F. Perseveration induced by methylphenidate in children: preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 269-273.
44. Izquierdo I., Bevilaqua L. R., Rossato J. I., Lima R. H., Medina J. H., Cammarota M. Age-dependent and age-independent human memory persistence is enhanced by delayed posttraining methylphenidate administration. Proc Natl Acad Sci U S A 2008; 105: 19504-19507.
45. Pigeau R., Naitoh P., Buguet A., McCann C., Baranski J., Taylor M. etal. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212-228.
46. Smith M. E., Farah M. J. Are prescription stimulants 'smart pills'? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 2011; 137: 717-741.